Species variation in the metabolism of 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one to its 3,4-dihydrodiol, the proximate carcinogen

• Published in: Carcinogenesis (New York) Vol. 16; no. 10; p. 2351
• Main Authors: Boyd, G W, Coombs, M M, Ioannides, C, Lewis, D F, Snelling, J, Tsakalof, A
• Format: Journal Article
• Language: English
• Published: England 01.10.1995
• Subjects: Animals; Binding Sites; Biotransformation; Carcinogens - chemistry; Carcinogens - metabolism; Chromatography, High Pressure Liquid; Cricetinae; Cytochrome P-450 Enzyme System - chemistry; Cytochrome P-450 Enzyme System - metabolism; Dogs; Gonanes - chemistry; Gonanes - metabolism; Haplorhini; Humans; Mice; Microsomes, Liver - metabolism; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Conformation; Rabbits; Rats; Species Specificity
• ISSN: 0143-3334
• DOI: 10.1093/carcin/16.10.2351

The title compound is a strong carcinogen, similar in potency to benzo[a]pyrene in mouse skin assay. This paper describes a comparison of its in vitro metabolism by hepatic microsomal preparations from mouse, rat, rabbit, hamster, dog, monkey and man. Metabolites were isolated by preparative high pressure liquid chromatography from the ethyl acetate extractable material and their structures tentatively assigned on the basis of their retention times and ultraviolet spectra, when possible by direct comparison with authentic synthetic specimens. Mass spectrometry was then used to confirm these assignments. All these animals produce the same range of metabolites derived exclusively from oxidation at the benzo-ring A, the five-membered ring D, and at the 11-methyl group. However, the amounts of individual metabolites varied substantially. In particular all the animals yielded the proximate carcinogen 3,4-dihydroxy-11-methyl-3,4,15, 16-tetrahydrocyclopenta[a]phenanthren-17-one, from which it is reasoned that all might be susceptible to its carcinogenic action. A rationalization for the observed distribution of the metabolites is proposed on the basis of a molecular model of the active site of cytochrome P450 1A1, the oxidative enzyme involved.